NPM1P20

Across TCGA pan-cancer cohorts, NPM1P20 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of NPM1P20’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where NPM1P20 RNA is repressed in tumor relative to normal tissue. In most cancer types NPM1P20 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

THCA and KIRC are the cancer types where NPM1P20 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in NPM1P20 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	All	−0.036	.006	6	view →
KIRC	Male	All	+0.038	.004	5	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

NPM1P20–THCA

Open the THCA breakdown →